Walgreens Boots Alliance (WBA) Misses Q3 EPS by 8c, Lowers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
TD Cowen on Walgreens Boosts Alliance (WBA): 'continued challenges in retail pharmacy'
June 27, 2024 8:51 AM EDTTD Cowen analyst Charles Rhyee reiterated a Buy rating and $35.00 price target on Walgreens Boosts Alliance (NASDAQ: WBA).
The analyst comments "F3Q adj EPS $0.63 missed cons $0.69. WBA narrowed FY24 guide to $2.80-$2.95 (from $3.20-$3.35), which assumes continued challenges in retail pharmacy.... More
RBC Capital on Walgreens (WBA): 'ongoing consumer weakness and pressure on pharmacy margin'
June 27, 2024 8:28 AM EDTRBC Capital analyst Anton Hie reiterated a Sector Perform rating and $22.00 price target on Walgreens Boosts Alliance (NASDAQ: WBA).
The analyst comments "WBA posted fiscal 3Q24 earnings slightly below expectations driven by ongoing consumer weakness and pressure on pharmacy margin, partially offset by another quarter of good International performance and positive EBITDA contribution from U.S. Healthcare. Management lowered its adjusted EPS guidance by $0.40 at the midpoint, or -12%... More
